ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell... ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.135 | -5.74468085106 | 2.35 | 2.57 | 2.14 | 3300086 | 2.42530984 | CS |
4 | -0.175 | -7.32217573222 | 2.39 | 2.57 | 2.07 | 1214564 | 2.40487362 | CS |
12 | -0.285 | -11.4 | 2.5 | 2.59 | 1.58 | 689622 | 2.34055791 | CS |
26 | 0.785 | 54.8951048951 | 1.43 | 4.44 | 1.4081 | 834506 | 2.59906936 | CS |
52 | -2.575 | -53.75782881 | 4.79 | 4.98 | 1.12 | 811653 | 2.28240051 | CS |
156 | -7.185 | -76.4361702128 | 9.4 | 14.19 | 1.12 | 477832 | 4.03573776 | CS |
260 | -7.185 | -76.4361702128 | 9.4 | 14.19 | 1.12 | 477832 | 4.03573776 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.